CELLCEPT 500 mg, powder for concentrate for infusion 4 bottles of 20 ml
Brand page: CellCept (mycophenolate mofetil) — all forms and strengths in France
Active ingredients: Mycophenolate mofetil hydrochloride, Mycophenolate mofetil
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for concentrate for infusion4 bottles of 20 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CELLCEPT 500 mg, poudre pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 4 flacon(s) en verre de 20 ml
- Marketing authorisation holder
- ROCHE REGISTRATION (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 21 May 1999
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63227488CIP75619394CIP133400956193943Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MYCOPHÉNOLATE MOFÉTILpoudre | 500 mg · un flacon | FT |
| CHLORHYDRATE DE MYCOPHÉNOLATE MOFÉTILpoudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.